Breakthrough Therapy Designation is based on the encouraging survival data from the Phase 1 BrainChild-03 trial in children and young adults with diffuse intrinsic pontine glioma (DIPG) BrainChild Bio ...
The Science Advances publication details Cellgorithmâ„¢, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...
Extending human health span by several years is the vision of clock.bio, a biotech startup that is investigating the biology of cellular rejuvenation. The company recently raised $5.3 million in seed ...